Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 30.

Ramming, A; Distler, J H W; Schett, G; Gay, S; Jüngel, A (2014). Epigenetische Modifikationen bei Autoimmunerkrankungen. Zeitschrift für Rheumatologie, 73(7):636-638.

Niederer, F; Trenkmann, M; Ospelt, C; Karouzakis, E; Neidhart, M; Stanczyk, J; Kolling, C; Gay, R E; Detmar, M; Gay, S; Jüngel, A; Kyburz, D (2012). Downregulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis and Rheumatism, 64(6):1771-1779.

Kollias, G; Papadaki, P; Apparailly, F; Vervoordeldonk, M J; Holmdahl, R; Baumans, V; Desaintes, C; Di Santo, J; Distler, J; Garside, P; Hegen, M; Huizinga, T W J; Jüngel, A; Klareskog, L; McInnes, I; Ragoussis, I; Schett, G; Hart, B; Tak, P P; Toes, R; van den Berg, W B; Wurst, W; Gay, S (2011). Animal models for arthritis: innovative tools for prevention and treatment. Annals of the Rheumatic Diseases, 70(8):1357-1362.

Karouzakis, E; Rengel, Y; Jüngel, A; Kolling, C; Gay, R E; Michel, B A; Tak, P P; Gay, S; Neidhart, M; Ospelt, C (2011). DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes and Immunity, 12(8):643-652.

Jüngel, A; Distler, J H W; Gay, S; Distler, O (2011). Epigenetic modifications: novel therapeutic strategies for systemic sclerosis? Expert Review of Clinical Immunology, 7(4):475-480.

Jüngel, A; Gay, S (2011). Epigentics in rheumatic diseases. Zeitschrift für Rheumatologie, 70(3):205-212.

Distler, J H W; Akhmetshina, A; Dees, C; Jüngel, A; Stürzl, M; Gay, S; Pisetsky, D S; Schett, G; Distler, O (2011). Induction of apoptosis in circulating angiogenic cells by microparticles. Arthritis and Rheumatism, 63(7):2067-2077.

Dees, C; Akhmetshina, A; Zerr, P; Reich, N; Palumbo, K; Horn, A; Jüngel, A; Beyer, C; Krönke, G; Zwerina, J; Reiter, R; Alenina, N; Maroteaux, L; Gay, S; Schett, G; Distler, O; Distler, J H W (2011). Platelet-derived serotonin links vascular disease and tissue fibrosis. Journal of Experimental Medicine, 208(5):961-972.

Jüngel, A; Gay, S (2011). miRNA in epigenetics of rheumatic diseases. Praxis, 100(1):37-43.

Maciejewska Rodrigues, H; Karouzakis, E; Strietholt, S; Hemmatazad, H; Neidhart, M; Ospelt, C; Gay, R E; Michel, B A; Pap, T; Gay, S; Jüngel, A (2010). Epigenetics and rheumatoid arthritis: The role of SENP1 in the regulation of MMP-1 expression. Journal of Autoimmunity, 35(1):15-22.

Jüngel, A; Ospelt, C; Lesch, M; Thiel, M A; Sunyer, T; Schorr, O; Michel, B A; Gay, R E; Kolling, C; Flory, C; Gay, S; Neidhart, M (2010). Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(5):898-902.

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Jüngel, A. Epigenetics in rheumatic diseases. 2010, University of Zurich, Faculty of Medicine.

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Maurer, B; Stanczyk, J; Jüngel, A; Akhmetshina, A; Trenkmann, M; Brock, M; Kowal-Bielecka, O; Gay, R E; Michel, B A; Distler, J H W; Gay, S; Distler, O (2010). MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis and Rheumatism, 62(6):1733-1743.

Jüngel, A; Ospelt, C; Gay, S (2010). What can we learn from epigenetics in the year 2009? Current Opinion in Rheumatology, 22(3):284-292.

Maciejewska Rodrigues, H; Jüngel, A; Gay, R E; Gay, S (2009). Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Molecular Immunology, 47(1):12-18.

Venalis, P; Maurer, B; Akhmetshina, A; Busch, N; Dees, C; Stürzl, M; Zwerina, J; Jüngel, A; Gay, S; Schett, G; Distler, O; Distler, J H W (2009). Lack of inhibititory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo. Journal of Cellular and Molecular Medicine, 13(10):4185-4191.

Hemmatazad, H; Maciejewska Rodrigues, H; Maurer, B; Brentano, F; Pileckyte, M; Distler, J H W; Gay, R E; Michel, B A; Gay, S; Huber, L C; Distler, O; Jüngel, A (2009). Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis and Rheumatism, 60(5):1519-1529.

Ospelt, C; Brentano, F; Jüngel, A; Rengel, Y; Kolling, C; Michel, B A; Gay, R E; Gay, S (2009). Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 60(2):355-363.

Sellam, J; Proulle, V; Jüngel, A; Ittah, M; Miceli Richard, C; Gottenberg, J E; Toti, F; Benessiano, J; Gay, S; Freyssinet, J M; Mariette, X (2009). Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Research & Therapy, 11(5):R156.

Kurowska-Stolarska, M; Distler, J H; Jüngel, A; Rudnicka, W; Neumann, E; Pap, T; Wenger, R H; Michel, B A; Müller-Ladner, U; Gay, R E; Maslinski, W; Gay, S; Distler, O (2009). Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis. Arthritis and Rheumatism, 60(12):3663-3675.

Huber, L C; Jüngel, A; Gay, S (2009). Targeting the epigenetic modifications of synovial cells. In: Tak, P P. New Therapeutic Targets in Rheumatoid Arthritis. Basel, Switzerland: Birkhauser / Springer, 193-206.

Maurer, B; Busch, N; Jüngel, A; Pileckyte, M; Gay, R E; Michel, B A; Schett, G; Gay, S; Distler, J; Distler, O (2009). Transcription factor Fos-Related Antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation, 120(23):2367-2376.

Akhmetshina, A; Dees, C; Pileckyte, M; Maurer, B; Axmann, R; Jüngel, A; Zwerina, J; Gay, S; Schett, G; Distler, O; Distler, J H W (2008). Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB Journal, 22(7):2214-2222.

Guiducci, S; Distler, J H W; Jüngel, A; Huscher, D; Huber, L C; Michel, B A; Gay, R E; Pisetsky, D S; Gay, S; Matucci-Cerinic, M; Distler, O (2008). The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism, 58(9):2845-2853.

Huber, L C; Distler, J H W; Moritz, F; Hemmatazad, H; Hauser, T; Michel, B A; Gay, R E; Matucci-Cerinic, M; Gay, S; Distler, O; Jüngel, A (2007). Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis and Rheumatism, 56(8):275-264.

Huber, L C; Jüngel, A; Distler, J H W; Moritz, F; Gay, R E; Michel, B A; Pisetsky, D S; Gay, S; Distler, O (2007). The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis, 12(2):363-374.

Distler, J H W; Jüngel, A; Huber, L C; Schulze-Horsel, U; Zwerina, J; Gay, R E; Michel, B A; Hauser, T; Schett, G; Gay, S; Distler, O (2007). Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis and Rheumatism, 56(1):311-322.

Distler, J H W; Jüngel, A; Huber, L C; Seemayer, C A; Reich, C F; Gay, R E; Michel, B A; Fontana, A; Gay, S; Pisetsky, D S; Distler, O (2005). The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(8):2892-2897.

This list was generated on Sat Feb 23 02:10:23 2019 CET.